Literature DB >> 1747990

Process of smoking cessation. Implications for clinicians.

J O Prochaska1, M G Goldstein.   

Abstract

The process of smoking cessation involves progression through five stages of change: precontemplation, contemplation, preparation, action, and maintenance. Most patients are not prepared to take action on their smoking, yet most smoking cessation programs are designed for smokers who are so prepared. Small percentages of smokers register for action-oriented cessation programs. How much progress patients make after an intervention is directly related to what stage they are in prior to intervention. The stages of change can be quickly assessed with four questions. Physicians can then be more effective with a broader range of patients by matching their interventions to the patients' stage of change. Helping patients progress just one stage can double their chances of not smoking 6 months later. Providing personalized information about the cons of smoking, asking affect-arousing questions, and encouraging patients to re-evaluate themselves as smokers are interventions physicians can use to help patients who are not prepared to quit smoking. Behavioral interventions, such as providing substitutes like nicotine gum and removing or altering cues for smoking, are most helpful for patients who are ready to take action. The use of a stage-matched, patient-centered counseling intervention can help physicians to feel less frustrated and more effective in their efforts to help a broad range of their patients.

Entities:  

Mesh:

Year:  1991        PMID: 1747990

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  63 in total

1.  An evidence-based programme for smoking cessation: effectiveness in routine general practice.

Authors:  G Grandes; J M Cortada; A Arrazola
Journal:  Br J Gen Pract       Date:  2000-10       Impact factor: 5.386

2.  [Recommendations on the diagnostic and therapeutic approach to smokers. Consensus document].

Authors:  M Torrecilla García; F Domínguez Grandal; A Torres Lana; C Cabezas Peña; C A Jiménez Ruiz; M Barrueco Ferrero; S Solano Reina; J I de Granda Orive; J L Díaz-Maroto Muñoz; J Alonso; M L Martínez; S García; E de la Cruz Amorós; R Abengozar Muela; F Ramos Postigo; J Ayesta
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

Review 3.  Assessment of dependence and motivation to stop smoking.

Authors:  Robert West
Journal:  BMJ       Date:  2004-02-07

Review 4.  Motivating and helping smokers to stop smoking.

Authors:  John R Hughes
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

5.  Predictors of long-term outcome of a smoking cessation programme in primary care.

Authors:  Gonzalo Grandes; Josep M Cortada; Arantza Arrazola; Jon P Laka
Journal:  Br J Gen Pract       Date:  2003-02       Impact factor: 5.386

6.  The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the Seychelles.

Authors:  A R Gilbert; C Pinget; P Bovet; J Cornuz; C Shamlaye; F Paccaud
Journal:  Tob Control       Date:  2004-06       Impact factor: 7.552

7.  Beyond the gadgets.

Authors:  Nancy M Lorenzi
Journal:  BMJ       Date:  2004-05-15

8.  Adherence to nicotine replacement therapy versus quitting smoking among Chinese smokers: a preliminary investigation.

Authors:  Tai-Hing Lam; Abu Saleh M Abdullah; Sophia S C Chan; Anthony J Hedley
Journal:  Psychopharmacology (Berl)       Date:  2004-07-29       Impact factor: 4.530

9.  A prospective study of household smoking bans and subsequent cessation related behaviour: the role of stage of change.

Authors:  B A Pizacani; D P Martin; M J Stark; T D Koepsell; B Thompson; P Diehr
Journal:  Tob Control       Date:  2004-03       Impact factor: 7.552

10.  Comparison of five measures of motivation to quit smoking among a sample of hospitalized smokers.

Authors:  C N Sciamanna; J S Hoch; G C Duke; M N Fogle; D E Ford
Journal:  J Gen Intern Med       Date:  2000-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.